Chlorin derivatives sterically-prevented from self-aggregation with high antitumor activity for photodynamic therapy
Source abstract
Abstract
Abstract In this study two new chlorin derivatives sterically prevented from aggregation were synthesised by the Diels-Alder reaction between protoporphyrin IX dimethyl ester and 1-(2-hydroxyethyl)maleimide. The compounds were fully characterised by 1 H NMR, 13 C NMR, UV-Vis and high-resolution mass spectroscopy (HRMS) and their photochemical properties such as singlet oxygen quantum yield (ϕ 0 ), fluorescence quantum yield (ϕ f ) and photodegradation were also evaluated. Furthermore, the partition coefficient (log P) revealed that these compounds present amphiphilic properties. Studies of the photodynamic action in tumour cells (HEp-2 and HeLa) and non-tumour cells (Vero) were also performed in order to confirm the photodynamic therapy (PDT) activity that was indicated by the preliminary photophysical studies. Those phototoxicity results were 55–77% higher than the results obtained with the commercial photosensitiser verteporfin. Finally, cytotoxic assays were performed with the new photosensitiser candidates and cell death was determined using fluorescence microscopy, which provided information about the mechanisms of cell death. In general, we have obtained improved and accessible compounds for PDT studies, as highlighted by the research presented here.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer10.1016/j.bmcl.2014.01.054 ↗
2. Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death10.1016/S1572-1000(05)00030-X ↗
3. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT10.1016/j.jphotobiol.2009.04.001 ↗
4. Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy10.1016/j.bmc.2013.02.005 ↗
5. In vitro demonstration of the heavy-atom effect for photodynamic therapy10.1021/ja047649e ↗
6. Synthesis and biological distribution study of a new carbon-11 labeled porphyrin for PET imaging. Photochemical and biological characterization of the non-labeled porphyrin10.1142/S1088424615500728 ↗
7. Synthesis, photophysical studies and anticancer activity of a new halogenated water-soluble porphyrin10.1111/j.1751-1097.2007.00073.x ↗
8. The role of porphyrin chemistry in tumor imaging and photodynamic therapy10.1039/B915149B ↗
9. Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy10.1016/j.biomaterials.2013.05.070 ↗
10. Physicochemical properties of potential porphyrin photosensitizers for photodynamic therapy10.1016/j.saa.2015.03.076 ↗
11. Amphiphilicmeso(sulfonate ester fluoroaryl)porphyrins: refining the substituents of porphyrin derivatives for phototherapy and diagnostics10.1016/j.tet.2012.08.007 ↗
12. Hydrophilic annulated dinuclear zinc(II) phthalocyanine as Type II photosensitizers for PDT: a combined experimental and (TD)-DFT investigation10.1142/S1088424613500569 ↗
13. Syntheses and properties of trimethylaminophenoxy-substituted Zn(II)-phthalocyanines10.1039/C1MD00232E ↗
14. Biomodulatory approaches to photodynamic therapy for solid tumors10.1016/j.canlet.2012.07.026 ↗
15. Photodynamic therapy (PDT) of cancer: from local to systemic treatment10.1039/C5PP00132C ↗
16. Efficient one-pot regioselective synthesis of 2,3-Dibromo-5,10,15,20-tetraarylporphyrins from 5,10,15,20-tetraarylchlorins
17. Synthesis and photophysical studies of a chlorin sterically designed to prevent self-aggregation10.1016/j.dyepig.2013.02.011 ↗
18. Efficient Photosensitization by a chlorin-polyoxometalate supramolecular complex10.1021/ic401729k ↗
19. Toward understanding the high PDT efficacy of chlorin e6-polyvinylpyrrolidone formulations: photophysical and molecular aspects of photosensitizer-polymer interaction in vitro10.1016/j.jphotobiol.2008.06.004 ↗
20. Spectroscopic and biological studies of a novel synthetic chlorin derivative with prospects for use in PDT10.1016/j.bmc.2009.10.029 ↗
21. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization10.1167/iovs.08-2833 ↗
22. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy10.1016/j.ajo.2010.10.030 ↗
23. A spectroscopic study of the photobleaching of protoporphyrin IX in solution10.1007/s10103-002-0254-2 ↗
24. Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy10.1016/j.pdpdt.2013.02.003 ↗
25. Modern aspects of the chemistry of protoporphyrin IX10.1134/S1070428007010010 ↗
26. Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
27. Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up10.1007/s00417-011-1883-6 ↗
28. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells10.1016/j.bbrc.2006.08.060 ↗
29. Photodynamictherapy of cancer. Basic principles and applications10.1007/s12094-008-0172-2 ↗
30. Vocal fold vibration after photofrin-mediated photodynamic therapy for treatment of early-stage laryngeal malignancies
31. Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer10.1016/j.ejps.2012.10.018 ↗
32. Photodynamic effects of mTHPC on human colon adenocarcinoma cells: photocytotoxicity, subcellular localization and apoptosis10.1562/0031-8655(2002)075<0406:PEOMOH>2.0.CO;2 ↗
33. Photodynamic therapy using Laserphyrin for centrally located early stage lung cancer10.1200/jco.2006.24.18_suppl.7229 ↗
34. Photodynamic therapy of C6-implanted glioma cells in the rat brain employing second-generation photosensitizer talaporfin sodium10.1016/j.pdpdt.2008.08.001 ↗
35. Photodynamic therapy and the development metal-based photosensitisers10.1155/2008/276109 ↗
36. Oncologic photodynamic therapy photosensitizers: a clinical review10.1016/j.pdpdt.2010.02.001 ↗
37. Current states and future views in photodynamic therapy10.1016/j.jphotochemrev.2011.06.001 ↗
38. Synthesis of functionalized chlorins sterically-prevented from self-aggregation10.1016/j.dyepig.2013.05.024 ↗
39. Synthesis of new amphiphilic chlorin derivatives from protoporphyrin-IX dimethyl ester10.1016/j.tet.2008.06.103 ↗
40. Syntheses and screening tests of new chlorin derivatives as photosensitizer10.1016/j.jphotochem.2005.02.009 ↗
41. Chlorin photosensitizers stericallydesigned to prevent self-aggregation10.1021/jo201568n ↗
42. Armarego · 2009
43. Thermoreversible reactions on inorganic nanoparticle surfaces: diels-alder reactions on sterically crowded surfaces10.1021/cm303049k ↗
44. Degradable cross-linkers and strippable imaging materials for step-and-flash imprint lithography10.1021/ma702291k ↗
45. Rate constants for the decay and reactions of the lowest electronically excited singlet-state of molecular-oxygen in solution. An expanded and revised compilation
46. A compilation of singlet oxygen yields from biologically relevant molecules10.1111/j.1751-1097.1999.tb08240.x ↗
47. Are fluorescence quantum yields so tricky to measure? A demonstration using familiar stationery product10.1021/ed076p1260 ↗
48. Determination of n-octanol/water partition and membrane binding of cationic porphyrins10.1016/j.ijpharm.2006.08.008 ↗
49. MTT assays allow quick and reliable measurement of the response of human tumour-cells to photodynamic therapy10.1016/0959-8049(92)90542-A ↗
50. The biochemical and cellular basis of cell proliferation assays that use tetrazoliumsalts
51. A simple technique for quantifying apoptosis in 96-well plates10.1016/B978-0-12-405914-6.00020-2 ↗
52. Pluronic® mixed micelles as efficient nanocarriers for benzoporphyrin derivatives applied to photodynamic therapy in cancer cells10.1016/j.jphotochem.2015.08.024 ↗
53. Novel organosoluble metal-free and metallophthalocyanines bearing triazole moieties: microwave assisted synthesis and determination of photophysical and photochemical properties10.1016/j.dyepig.2012.03.026 ↗
54. Previous illumination of a water soluble chlorine photosensitizer increases its cytotoxicity10.1134/S1054660X12090034 ↗
55. Photostability of different chlorine photosensitizers10.1002/lapl.200710099 ↗
56. 2012
57. Physicochemical determinants of the sensitizing effectiveness for photooxidation of nerve membranes by fluorescein derivatives10.1111/j.1751-1097.1979.tb07168.x ↗
58. Partition coefficient of amphiphilic chemicyanine dyes between the aqueous and the micellar phase of sodium dodecyl sulfate by differential absorbance spectroscopy10.1016/S0927-7757(98)00496-8 ↗
59. Do liposome-binding constants of porphyrins correlate with their measured and predicted partitioning between octanol and water?10.1562/0031-8655(2002)076<0127:DLBCOP>2.0.CO;2 ↗
60. Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice10.1006/mvre.1993.1024 ↗
61. Mechanisms in photodynamic therapy: Part three- Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction10.1016/S1572-1000(05)00060-8 ↗
62. Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative10.1038/bjc.1994.162 ↗
63. Photofrin accumulation in malignant and hostcell populations of a murine fibrosarcoma10.1111/j.1751-1097.1995.tb05253.x ↗
64. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform10.3389/fmicb.2012.00120 ↗
65. Reactive oxygen species: a breath of life or death?10.1158/1078-0432.CCR-06-2082 ↗